Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Khiron Life Sciences Corp KHRWF


Primary Symbol: V.KHRN.H Alternate Symbol(s):  V.KHRN.WT.H | KHRNF

Healthcare Cannabis
Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

Recent & Breaking News (TSXV:KHRN.H)

Khiron Reports Second Quarter 2020 Financial Results

Canada NewsWire August 24, 2020

Khiron Signs First Kuida(TM) Distribution Deal in Hong Kong

Canada NewsWire August 10, 2020

Khiron Provides Corporate Update: Surpasses 1,000 Medical Cannabis Patient Prescription Milestone

Canada NewsWire July 27, 2020

OTC Markets Group Announces Quarterly Index Performance and Rebalancing

PR Newswire July 24, 2020

Khiron to Commercialize Medical Cannabis in Peru

Canada NewsWire July 23, 2020

Khiron Announces Change of Auditor

GlobeNewswire July 21, 2020

Vamos Colombia! Khiron Hosts Live Virtual Medical Facility Tour

Canada NewsWire July 17, 2020

Khiron Expands EU Footprint, Signing Kuida(TM) Distribution Deal in Spain

PR Newswire July 2, 2020

Cannabis Industry Company Investor Presentations Now Available for On-Demand Viewing

Canada NewsWire June 26, 2020

Khiron Signs Distribution Deal in Germany for Medical Cannabis Imports and Sales

PR Newswire June 25, 2020

Khiron Goes Green, Completing 1 Megawatt Solar Energy Park in Colombia

PR Newswire June 24, 2020

Live Investor Conference & Webinar: Cannabis Industry Companies Present June 24th

Canada NewsWire June 22, 2020

Khiron CEO and Board Chair to Participate in Live Webcast on June 24th

PR Newswire June 22, 2020

Khiron Appoints Chris Naprawa to Director, and Chairman of the Board

Canada NewsWire June 12, 2020

Khiron Life Sciences Reports First Quarter Fiscal 2020 Financial Results

Canada NewsWire May 28, 2020

Khiron Begins Sales of First High-THC Medical Cannabis in Colombia

Canada NewsWire May 20, 2020

Khiron to Present at Canaccord Genuity's Global Cannabis Virtual Conference

Canada NewsWire May 7, 2020

Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21

Canada NewsWire May 6, 2020

Medicinal cannabis co. shares soar after striking Brazil distribution deal

Stockhouse Editorial May 4, 2020

Khiron Life Sciences Reports 2019 Fiscal Year End Results and Provides Corporate Update

Canada NewsWire May 1, 2020